• UGI USER
  • May 20, 2024
  • 11 Likes
  • 0 Comments

COVID VACCINE MAKERS PREPARE TO LAUNCH NEW-GENERATION JABS AMID VARIANT CONCERNS

Why in the news?

  • Hyderabad-based Biological E initiates clinical trials for next-generation Covid vaccine targeting the XBB1.5 variant.
  • Aimed at combating evolving strains of SARS-CoV-2, particularly amid rising cases worldwide.

About India SARS-CoV-2 Genomics Consortium (INSACOG):

  • India SARS-CoV-2 Genomics Consortium (INSACOG) initiated by the Health Ministry, DBT, CSIR, and ICMR.
  • Consists of 54 labs monitoring genomic variations in SARS-CoV-2 through sentinel sequencing.
  • Established to expand whole genome sequencing, aiding understanding of virus spread, evolution, and informing public health response.
  • Samples analyzed to observe genetic code changes and virus mutations, crucial for vaccine development and response strategies.
source:scribd
About the Covid Omicron XBB1.5 variant:

  • XBB.1.5 variant is a sub-variant of XBB.
  • It’s a combination of mutations from BA.2.75 and BA.2.10.1.
  • First reported in India.
  • Known for immune evasion and high contagiousness.